Late-Stage Active Oncology Drug Developers | An Overview
March 9, 2023
Antibody Drug Conjugates (ADCs) are therapeutic entities with monoclonal antibody (mAb) backbone linked to cytotoxic drugs and are designed to...
109 Antibody Drug Conjugates Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
90 Antibody Drug Conjugates Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
In 1986, muromonab-CD3 (OKT3) wins the first therapeutic monoclonal antibody approval from the US FDA, which works as an immunosuppressive...
updated.. easy.. precise... complete...
Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.
LEARN MORE »
Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.
Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.